Global Heparin Sodium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

According to our Researcher latest study, the global Heparin Sodium market size was valued at USD 2004.4 million in 2022 and is forecast to a readjusted size of USD 2491.8 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, etc. Global top five manufacturers hold a share about 60%. China is the largest market, with a share about 60%, followed by Europe and North America, total with a share about 35 percent. In terms of application, the largest application is Treatment of Venous Thromboembolism, followed by Cardioversion of Atrial Fibrillation/Flutter, and Treatment of Venous Thromboembolism, etc.

This report is a detailed and comprehensive analysis for global Heparin Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Heparin Sodium market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029

Global Heparin Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029

Global Heparin Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029

Global Heparin Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Heparin Sodium

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Heparin Sodium market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer and Dongcheng Biochemicals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Heparin Sodium market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Oral Type

Injection Type

Market segment by Application

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Other

Major players

covered

Shenzhen Hepalink

Bioibérica

Nanjing King-friend

Pfizer

Dongcheng Biochemicals

Changzhou Qianhong Bio-pharma

Changshan Biochemical

Pharma Action

Baxter

Dongying Tiandong Pharmaceutical

Opocrin

Aspen Oss

Xinbai Pharmaceuticals

Yino Pharma Limited

Sichuan Deebio

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Heparin Sodium product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Heparin Sodium, with price, sales, revenue and global market share of Heparin Sodium from 2018 to 2023.

Chapter 3, the Heparin Sodium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Heparin Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Heparin Sodium market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin Sodium.

Chapter 14 and 15, to describe Heparin Sodium sales channel, distributors, customers, research findings and conclusion.

Frequently Asked Questions